Human chorionic gonadotropin (hCG) and prevention of breast cancer
- 11 February 2007
- journal article
- case report
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 269 (1-2) , 93-98
- https://doi.org/10.1016/j.mce.2006.06.015
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Protein biomarkers for breast cancer preventionEuropean Journal Of Cancer Prevention, 2004
- Human Chorionic Gonadotropin Decreases Proliferation and Invasion of Breast Cancer MCF-7 Cells by Inhibiting NF-κB and AP-1 ActivationJournal of Biological Chemistry, 2004
- Luteinizing hormone receptor status and clinical, pathologic, and prognostic features in patients with breast carcinomasCancer, 2003
- Presence of Functional Luteinizing Hormone/Chorionic Gonadotropin (hCG) Receptors in Human Breast Cell Lines: Implications Supporting the Premise that hCG Protects Women against Breast CancerBiology of Reproduction, 1997
- Immunolocalization of inhibin in the mammary gland of rats treated with hCG.Journal of Histochemistry & Cytochemistry, 1993
- α-lnhibin is a tumour-suppressor gene with gonadal specificity in miceNature, 1992
- Effect of human chlorionic gonadoropin on mammary gland differentiation and carcinogenesisCarcinogenesis: Integrative Cancer Research, 1990
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- Glycoprotein Hormones: Structure and FunctionAnnual Review of Biochemistry, 1981
- Structure of Human Luteinizing Hormone Alpha SubunitEndocrine Research Communications, 1978